Health-related quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s | |
| Publication date | October 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S2152265019318646 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |